IDH2 and glioblastoma: The alterations detected by the panel included EGFRvIII, (EGFR transcripts with a deletion of exons 2–7) that is characteristic of a subset of IDH-wildtype GBM, and indeed all 19 cases with this transcript detected were IDH-wildtype GBM (Fig. 4a).